Caladrius Biosciences
Why Robinhood?
You can watch CLBS and buy or sell other stocks, ETFs, and their options commission-free!About CLBS
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors.
CLBS Key Statistics
Stock Snapshot
As of today, Caladrius Biosciences(CLBS) shares are valued at $2.66. The company's market cap stands at 23.5M, with a P/E ratio of -2.64.
On 2026-03-17, Caladrius Biosciences(CLBS) stock opened at —, reached a high of —, and a low of —.
The Caladrius Biosciences(CLBS)'s current trading volume is 0, compared to an average daily volume of 106.99K.
During the past year, Caladrius Biosciences(CLBS) stock moved between $1.81 at its lowest and $5.07 at its peak.
During the past year, Caladrius Biosciences(CLBS) stock moved between $1.81 at its lowest and $5.07 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.